Optimal Stem Cell Transporting Conditions to Maintain Cell Viability and Characteristics.

Na-Hee Yu, So Young Chun, Yun-Sok Ha, Hyun Tae Kim, Dae Hwan Kim, Jeongshik Kim, Jae-Wook Chung, Jun Nyung Lee, Phil Hyun Song, Eun Sang Yoo, Bum Soo Kim, Tae Gyun Kwon
Author Information
  1. Na-Hee Yu: 1Biomedical Research Institute, Kyungpook National University Hospital, 130 Dongdeok-ro, Jung-gu, Daegu, 41944 Korea.
  2. So Young Chun: 1Biomedical Research Institute, Kyungpook National University Hospital, 130 Dongdeok-ro, Jung-gu, Daegu, 41944 Korea.
  3. Yun-Sok Ha: 2Department of Urology, School of Medicine, Kyungpook National University, 130 Dongdeok-ro, Jung-gu, Daegu, 41944 Korea.
  4. Hyun Tae Kim: 2Department of Urology, School of Medicine, Kyungpook National University, 130 Dongdeok-ro, Jung-gu, Daegu, 41944 Korea.
  5. Dae Hwan Kim: 5Department of Laboratory Animal Research Support Team, Yeungnam University Medical Center, 170 Hyunchung-ro, Nam-gu, Daegu, 42415 Korea.
  6. Jeongshik Kim: Department of Pathology, Central Hospital, 480 Munsu-ro, Nam-gu, Ulsan, 44667 Korea.
  7. Jae-Wook Chung: 2Department of Urology, School of Medicine, Kyungpook National University, 130 Dongdeok-ro, Jung-gu, Daegu, 41944 Korea.
  8. Jun Nyung Lee: 2Department of Urology, School of Medicine, Kyungpook National University, 130 Dongdeok-ro, Jung-gu, Daegu, 41944 Korea.
  9. Phil Hyun Song: 7Department of Urology, College of Medicine, Yeungnam University, 170 Hyunchung-ro, Nam-gu, Daegu, 42415 Korea.
  10. Eun Sang Yoo: 2Department of Urology, School of Medicine, Kyungpook National University, 130 Dongdeok-ro, Jung-gu, Daegu, 41944 Korea.
  11. Bum Soo Kim: 2Department of Urology, School of Medicine, Kyungpook National University, 130 Dongdeok-ro, Jung-gu, Daegu, 41944 Korea. ORCID
  12. Tae Gyun Kwon: 2Department of Urology, School of Medicine, Kyungpook National University, 130 Dongdeok-ro, Jung-gu, Daegu, 41944 Korea.

Abstract

BACKGROUND: The preservation of stem cell viability and characteristics during cell transport from the bench to patients can significantly affect the success of cell therapy. Factors such as suspending medium, time, temperature, cell density, and container type could be considered for transport conditions.
METHODS: To establish optimal conditions, human amniotic fluid stem cells' (AFSCs) viabilities were analyzed under different media {DMEM(H), DMEM/F-12, K-SFM, RPMI 1640, α-MEM, DMEM(L), PBS or saline}, temperature (4, 22 or 37 °C), cell density (1 × 10 cells were suspended in 0.1, 0.5, 1.0 or 2.0 mL of medium) and container type (plastic syringe or glass bottle). After establishing the transport conditions, stem cell characteristics of AFSCs were compared to freshly prepared cells.
RESULTS: Cells transported in DMEM(H) showed relatively higher viability than other media. The optimized transport temperature was 4 °C, and available transport time was within 12 h. A lower cell density was associated with a better survival rate, and a syringe was selected as a transport container because of its clinical convenience. In compare of stem cell characteristics, the transported cells with established conditions showed similar potency as the freshly prepared cells.
CONCLUSION: Our findings can provide a foundation to optimization of conditions for stem cell transport.

Keywords

References

  1. J Neuropathol Exp Neurol. 2001 Aug;60(8):741-52 [PMID: 11487048]
  2. Biotechnol Bioeng. 2003 May 20;82(4):403-14 [PMID: 12632397]
  3. Ann Neurol. 2005 Jun;57(6):874-82 [PMID: 15929052]
  4. Stem Cells. 2006 Feb;24(2):462-71 [PMID: 16109759]
  5. Cell Death Differ. 2005 Nov;12 Suppl 2:1473-7 [PMID: 16247493]
  6. Exp Biol Med (Maywood). 2006 Jan;231(1):39-49 [PMID: 16380643]
  7. Am J Physiol Heart Circ Physiol. 2006 Jun;290(6):H2196-203 [PMID: 16473959]
  8. EMBO Rep. 2006 Apr;7(4):385-9 [PMID: 16585939]
  9. Infect Immun. 2007 Feb;75(2):553-64 [PMID: 17088348]
  10. Hum Reprod. 2008 Aug;23(8):1760-70 [PMID: 18541648]
  11. Microvasc Res. 2009 May;77(3):370-6 [PMID: 19249320]
  12. Cytotherapy. 1999;1(2):123-33 [PMID: 19746589]
  13. Cytokine Growth Factor Rev. 2009 Oct-Dec;20(5-6):419-27 [PMID: 19926330]
  14. Transfusion. 2011 Jan;51(1):137-47 [PMID: 20609197]
  15. Microb Ecol. 2010 Nov;60(4):894-902 [PMID: 20878521]
  16. J Transl Med. 2011 Mar 08;9:26 [PMID: 21385453]
  17. Stem Cells Dev. 2012 Jul 20;21(11):1911-23 [PMID: 22066606]
  18. Arch Pharm Res. 2012 Feb;35(2):271-80 [PMID: 22370781]
  19. Tissue Eng Part C Methods. 2013 Jul;19(7):568-76 [PMID: 23199013]
  20. Cytotherapy. 2013 Apr;15(4):460-6 [PMID: 23318345]
  21. Tissue Eng Part A. 2013 Jun;19(11-12):1416-23 [PMID: 23360404]
  22. Bone Marrow Transplant. 2014 Apr;49(4):469-76 [PMID: 24076548]
  23. Eur J Pharm Biopharm. 2014 Apr;86(3):459-68 [PMID: 24240028]
  24. Stem Cells. 2014 Sep;32(9):2430-42 [PMID: 24805247]
  25. Cytotherapy. 2015 Jan;17(1):38-45 [PMID: 25457275]
  26. Stem Cell Res Ther. 2015 Jan 27;6:11 [PMID: 25971703]
  27. Stem Cells Int. 2016;2016:1764938 [PMID: 27022399]
  28. Bone Marrow Transplant. 1995 Oct;16(4):557-64 [PMID: 8528172]
  29. Arch Microbiol. 1996 Nov;166(5):293-300 [PMID: 8929274]
  30. Stem Cells. 1997;15 Suppl 1:275-80 [PMID: 9368351]
  31. Biochim Biophys Acta. 1997 Oct 17;1342(2):119-31 [PMID: 9392521]

Word Cloud

Created with Highcharts 10.0.0celltransportstemconditionsdensitycellsCellcharacteristicstemperaturecontainer0viabilitycanmediumtimetypefluidAFSCsmediaHDMEM1syringefreshlypreparedtransportedshowedBACKGROUND:preservationbenchpatientssignificantlyaffectsuccesstherapyFactorssuspendingconsideredMETHODS:establishoptimalhumanamnioticcells'viabilitiesanalyzeddifferent{DMEMDMEM/F-12K-SFMRPMI1640α-MEMLPBSsaline}42237 °C1 × 10suspended520 mLplasticglassbottleestablishingcomparedRESULTS:Cellsrelativelyhigheroptimized4 °Cavailablewithin12 hlowerassociatedbettersurvivalrateselectedclinicalconveniencecompareestablishedsimilarpotencyCONCLUSION:findingsprovidefoundationoptimizationOptimalStemTransportingConditionsMaintainViabilityCharacteristicsAmniotictransportingMedium

Similar Articles

Cited By